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SUMMARY 
Convergence in health expenditure in the countries of the European Union (EU) has been 
demonstrated to be occurring in previous studies. The aim of this paper is to identify and 
discuss the reasons for this finding and to present new evidence confirming convergence in 
health outcomes, as represented by life expectancy and infant mortality rates. The statistical 
methods used, σ and β-convergence analysis, are well established in macro-economic growth 
analyses and based on the neo-classical growth model which predicts convergence in income 
for homogenous countries such as those forming the EU.  The analyses reveal a common 
trend in that Southern Mediterranean countries have generally exhibited upward convergence 
towards the mean in health expenditure, and convergence towards the EU mean in  improving 
directions for health outcomes.  In contrast, EU countries of the North, particularly those of 
Scandinavia, exhibit downward convergence towards the EU mean or below it in health 
expenditure, whilst their health outcome measures have generally been displaying a 
decreasing advantage over the EU mean over the periods of analysis. The results are briefly 
considered in relation to the factors that help to explain the results, including the question of 
whether a causal relationship between health expenditure and health outcomes exists, the 
nature and impact of health care reforms throughout the 1970s, 80s and 90s in countries 
contributing most to the observed convergence, and the predictions of the neo-classical 
growth model which underpin the results. 
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1.  INTRODUCTION 
Convergence, in sociological terms, is defined as ‘the result of a process in which the 
structures of different industrial societies come increasingly to resemble each other’ (Jary and 
Jary, 1991, p.121).  The concept of convergence therefore, taking the term ‘structures’ in its 
broadest sense, can be applied to almost any situation in which there are forces encouraging 
individuals, peoples, societies, institutions or nations towards a common point.  These forces 
may be social, political or economic in nature. 
 
In terms of industrial development there is the potential for individuals, for example, to 
converge on centres of industrial production, to converge in their living arrangements, their 
incomes, their wealth and their lifestyles.  On a macroeconomic basis, there is the potential 
for nation states to converge in terms of per capita GDP, inflation, output and a range of other 
indicators.  Convergence, moreover, is a word which has implications for the re-distribution 
of wealth, for concepts of equality, for right of access to welfare and health and equity in 
terms of other socio-economic indicators related to individuals and states.  Convergence 
towards total equality, however, has its limitations, as witnessed by the collapse of the 
command economies of the former Eastern Bloc countries, and indeed healthy differentials 
may be an essential ingredient of a successful modern industrial state. However, it is clearly 
the case that convergence towards certain minimum standards is a laudable goal in its own 
right and is being actively pursued and encouraged in the EU through a process of greater 
political, social and economic integration, laid down at its conception in the Treaty of Rome 
and re-enforced by the later Treaties of the EU (principally Maastricht and Amsterdam). 
 
However, even though the various treaties and mechanisms of the EU tend to generate forces 
for convergence at the level of public health (Hitiris and Nixon, 2000b), in EU Social Policy 
matters there is no current overt aim to standardise health care systems (Hoffmeyer and 
McCarthy, 1994) and the principles of subsidiarity lie at the heart of EU health care policy.  
In spite of this, the Commission of the European Communities (1994) has pointed out the 
reforms that have been introduced by member states throughout the 1980s and 90s in 
response to crisis constraints (see also OECD (1992); OECD (1994a) and Ham (1997) 
regarding reforms of health care systems), brought about by the now well established demand 
drivers of new health technologies, ageing populations, and greater awareness of what 
interventions are available. 
 
These, in conjunction with increased dissemination of information and movement of EU 
citizens and professionals, the Commission argued, may lead member states to seek ‘long-
term solutions in similar directions’ (ibid, p.40). Abel-Smith et al. (1995) also considered a 
possible agenda for EU health care policy in relation to reforms and McKee et al. (1996) have 
examined the influence of European law on health care provision, both of which may well 
encourage greater convergence.  As the EU also has a number of policy instruments to 
encourage greater re-distribution of wealth and investment throughout the EU
1, it is likely that 
this leads to convergence in GDP income which has knock-on effects for health care 
expenditure as these two variables have been shown to be highly correlated (Newhouse, 
1977). 
                                                 
1 Two prominent mechanisms exist: The European Regional Development Fund (ERDF) which provides grants 
for development projects in poorer regions.  It has the expressed aim of reducing imbalances between regions of 
the EU (and therefore a force for convergence). The second is the European Social Fund which provides 
financial assistance for vocational training, retraining and job-creation schemes (Hitiris, 1998). Convergence of Health Care Spending and Health Outcomes in the European Union, 1960-95  2
Previous studies have demonstrated that statistically significant convergence in GDP income 
and health care expenditure occurred in the current member states of the EU over the period 
1960-95 (Nixon, 1999; Hitiris and Nixon, 2000a; Hitiris and Nixon, 2000b). 
 
The aim of this paper is to briefly summarise these results and then go on to present the 
findings of convergence analyses of health outcomes in the member states of the EU using the 
same methodology. The paper begins with an overview of the theory of convergence and 
following this a brief description of the two statistical tests appropriate for the measurement 
of convergence is provided.  After summarising the results for health expenditure 
convergence, the results for health outcomes, represented by life expectancy and infant 
mortality, are provided, followed by an analysis of the results in the light of the expectations 
of the neo-classical growth model, and an examination of the potential causal link between 
health expenditure convergence and health outcomes.  Finally an outline is provided of health 
care reforms for countries contributing most to the observed convergence before coming to 
conclusions regarding the findings.  
 
The present fifteen countries of the EU are identified in tables and outputs by their associated 
abbreviations; A = Austria,  B = Belgium, D =  Germany, DK = Denmark, E = Spain, F = 
France, FIN = Finland, GR = Greece, I = Italy, IRL = Ireland, L = Luxembourg, NL = the 
Netherlands, P = Portugal, S = Sweden and UK = the United Kingdom. 
 
2.  THE THEORY OF CONVERGENCE ANALYSIS 
A more comprehensive description of the principal elements of theory is outlined elsewhere 
(Nixon (1999); Hitiris and Nixon, 2000a).  In brief, the theoretical base of economic 
convergence derives from the neo-classical growth model which produces the result that in 
the long-run all countries tend to a common equilibrium level of income per head, the steady 
state, if: (i) competition is perfect and trade is free; (ii) technologies are common across states 
and exhibit constant returns to scale and capital productivity is decreasing; and (iii) countries 
share similar preferences, then growth rates of income per head across states are inversely 
related to initial conditions. Therefore, an initially poorer economy with a lower starting value 
of the capital/labour ratio tends to grow faster than a richer one. 
 
Consequently, over time countries will tend to converge to the steady state with the same 
level of income per head, regardless of their initial conditions.  Although it is evident that 
differences do exist across the member states of the EU, they generally meet the above 
conditions for convergence according to the neo-classical growth model by aspiring to: a 
reduction in heterogeneity across member states in respect of the structure of markets and 
institutions; an increase in competition and economic openness through trade in goods and 
services; the facilitating of factor movements and technology transfers; a promotion of policy 
harmonisation.  Under these influences economic integration speeds up growth and facilitates 
the process of convergence (Sachs and Warner, 1995). 
 
In terms of attempting to test the hypothesis of convergence it is necessary to utilise 
longitudinal and time-series data (Leonardi, 1995).  The longitudinal aspect involves the 
chosen dependent variables, and the time-series aspect involves an examination of the data at 
chosen points in time.  It is possible to examine the data cross-sectionally at discrete points in 
time or to utilise panel data, in which case the data set is examined every year.  In so doing 




dependent variables are either converging or diverging the aim would be to seek to explain 
these changes by an examination of explanatory variables and policy changes. 
 
A number of methods are discussed in the literature which are used to test for the presence of 
convergence, and two principal concepts have been developed within the study of economic 
growth.  These methods have been adapted for use in the present study and are briefly 
outlined in the following. 
 
2.1  σ-convergence 
This approach concerns ‘cross-sectional dispersion’ in which convergence exists if, for 
example, the standard deviation (s.d.) (often its log) or coefficient of variation (c.v.) of a 
variable across a group of countries declines over time. Essentially, as standard deviation is a 
measure of the spread of data and is defined as ‘a numerical measure of the average 
variability of a data set around its mean’ (Sandy, 1990, p.52) if its value diminishes with 
successive measures over time this will support the hypothesis of convergence.  This form of 
convergence is known as σ-convergence  (Easterlin, 1960; Borts and Stein, 1964; Streissler, 
1979; Barro, 1984; Baumol, 1986; Dorwick and Nguyen, 1989; Barro and Sala-i-Martin, 
1991, 1992a, 1992b).  In order to statistically test for σ-convergence it is necessary to analyse 
the variance in the data over two points in time, and a method for doing this has been 
developed by the author as outlined in the methods section. 
 
In terms of graphical representations of convergence, Leonardi (1995) put forward a useful 
methodology for the study of economic and social convergence and the various hypotheses 
and scenarios he provides are described as: 1) the equivalent growth hypothesis, 2) the 
upward convergence scenario, 3) the downward convergence scenario, 4) the reversal of roles 
scenario, and 5) the divergence hypothesis.  These are illustrated graphically in Figures 1(a) 
to 1(e) and are helpful in explaining the results of σ-convergence analyses. 
 
2.1.1.  Equivalent growth hypothesis 
Figure 1(a) shows that although there is an absolute increase in the dependent variable for 
both A and B between time periods 1 and 2, there is no relative change between the two.  In 
this case both A and B experience the same growth and convergence does not take place 
between the two time periods. 
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2.1.2.  Upward convergence scenario 
Figure 1(b) illustrates the case of upward convergence, based on neofunctionalist integration 
theories (ibid, p.66).  Between time periods 1 and 2, B experiences low growth in real terms 
but A experiences real and upward growth towards the value attained by B.  This scenario is 
therefore classified as upward convergence as the initially inferior position of A is increasing 
at a faster rate than B. 







Time 1 Time 2
The gap narrows
over time with
growth A > B
 
 
2.1.3.  Downward convergence scenario 
In this scenario, as illustrated in Figure 1(c), the relative gap between A and B reduces 
between time periods 1 and 2, with A, the inferior, increasing in value and B, the superior, 
decreasing in value.  In spite of this, the initial ranking of A and B is unaltered by the 
convergence process. 







Time 1 Time 2
The gap narrows
over time with B
in decline




2.1.4.  Reversal of roles scenario 
As the title implies, over time periods 1 and 2 there is a reversal in the rank order of the two 
values, A and B, as shown in Figure 1(d).  This may be due to the dynamics of either growth 
or decrease in the value attained by A, or a growth or a decline in the value attained by B.  
The result is that absolute differences still exist between A and B. 







Time 1 Time 2
A and B change




2.1.5.  The divergence hypothesis 
Figure 1(e) depicts this situation in which, over time, the absolute gap between A and B 
increases, even though growth may be taking place for both A and B.  In this scenario the rate 
at which growth is occurring is sufficiently different such as to create a widening gap between 
the inferior and the superior. 







Time 1 Time 2
The gap increases
over time as growth
B > A
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2.2  β-convergence 
The disadvantage of σ-convergence is that it may be disproportionately influenced by 
discontinuities, outliers and short-run shocks. Additionally, the existence of a diminution of 
standard deviation or coefficient of variation does not confirm that a country approaching the 
sample mean will remain there as exemplified by the reversal of roles scenario described in 
Figure 1(d).  The second approach limits these shortcomings, positing that convergence exists 
if a poor economy tends to grow at a faster (but diminishing) rate than a rich one such that the 
poor country tends to catch up in terms of per capita income or product.  This property 
corresponds to the concept known as β-convergence (Barro, 1984; Baumol, 1986; DeLong, 
1988; Barro, 1991; Barro and Sala-i-Martin, 1991, 1992a, 1992b; Sala-i-Martin, 1994; Boyle 
and McCarthy, 1997). β-convergence is also known as ‘regression to the mean’ (Barro and 
Sala-i-Martin, 1995, p. 383), which is a point of focus in the methods adopted in the present 
paper. 
 
β-convergence is usually tested for by regression analysis of the log of first-differences of 
income per head, Yt+1 - Yt, explained by the log of income levels, Yt , a set of auxiliary 
conditional variables, Xt, and a set of dummy variables, Di, standing for latent characteristics 
of the i=1, 2,... countries in the sample. Formally: 
 
                    Yt+1 - Yt =  α + β Yt   +  δXt  + γDi.                                            (1) 
 
Evidence of β-convergence requires that the estimated coefficient, β, which measures the 
speed of convergence, is negative, β<0. Therefore, β≥0 implies that no convergence occurs. 
 
Within this method of analysis two forms of convergence are distinguished: conditional and 
absolute. Conditional convergence occurs if the estimated coefficient or coefficients of the 
auxiliary variables are statistically significant, indicating that there are differences across 
countries which direct each one to converge to its own steady state, allowing the possibility of 
‘convergence clubs’ to be formed
2. Alternatively, absolute convergence indicates that all 
countries in the sample converge to the same steady state. Figure 2 illustrates the case of 
absolute convergence for countries which begin with different initial conditions but reach a 
common steady state in the long run.  
 
A review of the literature shows that some debate exists as to the application  and 
interpretation of these two forms of convergence measurement (Bernard and Durlauf, 1996; 
Friedman, 1992; Quah, 1993) but the methods adopted in the present paper seek to address, 
and as far as possible, minimise the effects of these issues. 
 
2.3  Data selection 
Even with the best intentions and an intuitive feel for what is happening in a given situation, 
any research will stand or fall by the quality of its data.  In this respect data should be 
reliable, operationalised over time,  and valid (Leonardi, 1995, p.61).  In attempting to 
measure convergence it is essential, therefore, that data are consistent between the entities 
being measured, and do not change over time such that the original comparisons become 
invalid.  In attempting any cross-national analysis this is clearly problematic and rigorous 
                                                 
2 Convergence clubs occur when sub-groups of countries in a sample converge to a similar level, which is 




testing for consistency may force the researcher to limit data to only that which meets the 
above criteria. 
 








The source of the data is therefore an important issue and should meet with the requirements 
identified above.  This illustrates the principle of the need to obtain comparable data of the 
required quality over a sufficiently long period of time to asses the presence, or otherwise, of 
convergence. 
 
2.4  Measuring the rate of convergence 
The rate of convergence can be measured in two ways, namely in absolute or in relative 
terms.  In the former the dependent variable is expressed in its current value and in the latter 
case values are ranked or given in relative changes on an index vis-à-vis a common reference 
point (ibid, p. 64).  In this study an indexed mean of 100 is used as outlined in the methods 
section. Once these have been established, comparisons can either be made externally 
between all or selected member states or internally which provides a comparison with a 
state’s own development over the time periods examined. 
 
This brief review of the literature and principal methods used to test for convergence provides 
a means of analysing health care expenditure and health outcomes in the EU and to identify 
the specific countries that have been contributing most to any observed convergence. The 
particular methods adopted here allow for the testing of both β-convergence  and  σ-
convergence. 
 
3.  STUDY METHODS 
In this study use is made of OECD data on health (OECD/CREDES, 1997) which provides a 
reliable source in relation to the criteria identified in the theory sections above. 
 
In the testing of σ-convergence, data are separated by a 10-year period for the first four and a 
five year period for the last two; 1960, 1970, 1980, 1990, 1995 (the earliest and latest years, at Convergence of Health Care Spending and Health Outcomes in the European Union, 1960-95  8
analysis, for which a complete set of OECD data are available). The following hypotheses are 
applied to all health expenditure and health outcome variables for this form of analysis: 
 





  Alternative hypothesis,   HA: σ
2
60 >  σ
2
95  







2 , where s60
2
 is the standard 
deviation squared for 1960 of observations n = 15, and s95
2
 is the standard deviation squared 
for 1995 of observations n = 15.  The rejection rule is to reject the null hypothesis if F>F(n-1, 
α).  In order to overcome the effects of changing means over time which, without correction 
which leads to misrepresentations, the data used in the sample are converted to values around 
an indexed mean of 100 for each year. This method of calculation yields the coefficient of 





=× 100, preventing the problems associated with Galton’s 
falacy (Friedman, 1992).  Graphical representations of the results are used to provide 
descriptive analyses in accordance with the five hypotheses/scenarios of Leonardi. 
 
In order to test for β-convergence a panel data set was used from the same source 
(OECD/CREDES, 1997), covering a shorter period of 1980-1995, consisting of 16 time-series 
observations for each of the 15 EU member states (the cross-sectional units), i.e., 16x15=240 
observations. The analysis is applied to all health expenditure and health outcome variables. 
The estimation was based on regression analysis in the form of equation (1) and the results 
were tested for compliance with both economic and statistical criteria
4.  In order to test the 
hypothesis of absolute convergence it is necessary to examine the value of β and its statistical 
significance, with negative values confirming the presence of β-convergence.  To test the 
hypothesis of conditional convergence, in addition to the finding of β<0, the coefficients of 
the auxiliary variables will also need to be statistically significant. The principal variables 
which were subjected to both σ and β-convergence analysis were as follows: 
 
Health care expenditure:  total health care expenditure as a percentage of GDP; total 
per capita health expenditure in PPP$
5. 
 
Health outcomes:  life expectancy (females) at birth; life expectancy (males) at birth; 
infant mortality.  
 
The auxiliary variable used in the health expenditure analysis was national income, and in the 
health outcome analysis these were GDP income, health expenditure, number of in-patient 
hospital beds, in-patient length of stay, in-patient admission rate, number of in-patient beds 
per head of population and number of physicians per head of population. 
                                                 
3 The F-test (one-sided) is calculated by dividing the variance of one sample by the variance of a second sample. 
4 The econometric software package SHAZAM was used and the method of estimation takes account and 
corrects econometric problems arising from the nature of the sample of the pooled set of country data which is 
expected to be cross-sectionally correlated and time-wise autoregressive.  For further details about the estimation 
and results see: Hitiris and Nixon (2000a). 
5 For the EU the share of this expenditure coming from public finances represents approximately 75% - for 




4.  RESULTS  
4.1   σ-convergence for health expenditure 
The results for σ-convergence for both health care spending as a percentage of GDP and per 
capita spending are shown, by means of the trends in standard deviation (i.e. coefficient of 
variation resulting from the indexing described above) of the indexed scores, in Figure 3.   
 
In the case of spending as a percentage of GDP it can be seen that from 1960 the s.d. (c.v.) 
fell continuously from a figure of 32.2 in 1960 to 16.3 in 1995.  For per capita PPP$ spending 
a similar trend is observed with s.d. (c.v.) falling from a figure of 50.23 in 1960 to 30.61 in 
1995. It is interesting to note that there is a greater spread of data as shown by the standard 
deviation differences, in other words greater inequality, in per capita spending.  This 
indicates that the differences at the policy level (share of GDP allocated to health care) are 
less than those achieved in per capita terms, reflecting the relative strengths of EU countries 
in terms of GDP income in relation to their population sizes and spending preferences for 
health. This implies that use of health care spending as a percentage of GDP, the most widely 
used in international comparisons, has some limitations in reflecting what is spent at the 
citizen level. Expenditure per head in standard units of money is therefore perhaps a better 
indicator of convergence. 












s.d. (expend. % GDP)
s.d. (per capita exp.)
 
 





95 (p = 0.008) for % of GDP and (p = 0.039) for per capita spending.  
These results thus provide statistically significant evidence to show that this form of 
convergence occurred between 1960 and 1995 in both measures of health care expenditure. 
 
4.2  β-convergence for health expenditure 
The results of the β-convergence analysis show that in the estimation of absolute convergence 
the β coefficient is both negative and statistically significant.  For percentage of GDP β = 
-0.107 (standard error, 0.021) p<0.05; for per capita health expenditure β = -0.027 (standard 
error, 0.009), p<0.05.  These results confirm those of the σ-convergence analysis and as the 
magnitude of β is greater for the dependent variable share of GDP it indicates that this 
variable is converging at a faster rate than per capita expenditure.   Convergence of Health Care Spending and Health Outcomes in the European Union, 1960-95  10
The results for conditional convergence, taking GDP income as the auxiliary variable, show 
that for share of GDP the results are not statistically significant, confirming absolute 
convergence at the policy level.  However, for per capita expenditure there is evidence of 
strong conditional convergence with β = -0.064 (standard error, 0.014), p<0.05.  This result 
reflects the findings of the σ-convergence regarding greater differences between EU countries 
in terms of this variable in comparison with percentage of GDP.  The findings indicate, 
therefore, that in the long-run a number of per capita health expenditure clubs may be in 
evidence, and although they will tend to converge to their own steady state, they will go to 
different levels because of differences in GDP income across the EU. 
 
4.3  σ-convergence for health outcomes 
The results for σ-convergence for all three health outcome variables are shown by means of 
the trends in s.d. (c.v.) of the indexed scores as recorded in Figure 4. 
 
The s.d. (c.v.) of the indexed values for infant mortality rose from 45.9 to 47.1 between 1960 
and 1970 (p = 0.54, NS), and also rose from 16.8 to 19.6 between 1990 and 1995 (p = 0.71, 
NS), indicating two periods of non-significant divergence.  However, between 1970 and 1990 
there was sustained convergence from an s.d. (c.v.) of 47.1 to a figure of 16.1  (p = 0.0002), 
indicating statistically significant σ-convergence.  It is therefore possible to reject the null and 
accept the alternative hypothesis for infant mortality for this period of analysis. 
 

















s.d. life exp. (F)
s.d. life exp. (M)
 
 
For life expectancy (females) the s.d. (c.v.) scores show that overall and continuous 
convergence occurred between 1960 and 1990 with the s.d. (c.v.) falling from 2.8 in 1960 to 
1.3 in 1990 (p = 0.15, NS).  For the period 1990-95 there was a slight degree of divergence as 
the s.d (c.v.) rose to a figure of 1.4 (p = 0.59, NS), although neither of these changes are 
statistically significant.  These results indicate that a high degree of convergence has been 
established in life expectancy for females (c.v. values are small in comparison with infant 
mortality) and that there is limited room for significant reductions in differences across the 
countries of the EU. 
 
The results for life expectancy (males) reveal that continuous σ-convergence occurred 
between 1960 and 1990 with the s.d. falling from 4.0 in 1960 to 1.6 in 1990 (p = 0.001), a 
statistically significant change.  Between 1990 and 1995 no convergence or divergence 
occurred as the values are identical for both years.  Over the period 1960-95, it is possible to 




therefore differences in this variable have been diminishing but again, little room seems to 
remain for significant further convergence as the s.d. (c.v.) in this variable is very low.  
 
4.4  β-convergence for health outcomes 
The results of the β-convergence analysis for infant mortality revealed significant findings for 
absolute convergence but not for conditional convergence. The β coefficient is negative and 
statistically significant with value β = -0.163 (standard error, 0.026), p<0.05. Therefore, the 
hypothesis of β-convergence is confirmed. The results satisfy the conditions for strong 
convergence and suggest that in the long-run steady states apply to all EU countries for infant 
mortality. 
 
Similar results are found for life expectancy in females for only absolute  convergence 
producing statistically significant results, with β = -0.262 (standard error, 0.036), p<0.05.  
Again the results allow us to accept the hypothesis of strong β-convergence for this health 
outcome. 
 
4.5  Graphical analysis - health expenditure 
In order to identify the countries which have contributed most to the observed convergence in 
health expenditure two histograms are first provided covering the period 1960-95 and 
including all 15 countries, associated with the σ-convergence results.  Although not presented 
here, the graphs for β-convergence and the associated panel data re-enforce the following 
observed trends. 
 
The standardised results for s.d. (c.v.) for percentage of GDP and per capita spending are 
shown in Figures 5 and 6, respectively. 
 
In terms of the equivalent growth hypothesis it can be seen from Figures 5 and 6 that no 
countries achieve this although France and the Netherlands perhaps come closest to achieving 
it in terms of health care spending as a percentage of GDP (Figure 5) and France for per 
capita spending (Figure 6).  These countries have therefore achieved the greatest stability in 
relation to the EU mean for these variables.  
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In terms of the upward convergence scenario, for health care expenditure it can be seen from 
Figure 5 that four countries achieved upward convergence, namely Belgium (1970-90), Spain, 
Luxembourg (1960-90) and Portugal, with both Belgium and Portugal achieving reversal of 
roles to a value above the EU mean in 1995.  All four countries reached values close to the 
mean in 1995 from a position at the bottom of the scale with values below half the mean in 
1960.  
 
When we examine Figure 6, it is evident that this upward convergence is also reflected in per 
capita spending for these four countries, although the relative weakness of the currencies of 
Spain and Portugal, in contrast to the strength of the currency of Belgium and Luxembourg, 
becomes apparent.  Spain and Portugal, in 1995, achieved only approximately 75% of the EU 
mean in per capita spending whilst Belgium had close to parity between % of GDP and per 
capita spending, but Luxembourg achieved a value of approximately 149.6% of the EU mean, 
even though in % of GDP terms, all these countries were spending something close to the 
mean.  It is recognised here, however, that growths in the size of population will reduce the 
value of per capita PPP$ values as well as relative purchasing power. Thus although these 
countries have clearly introduced policies and reforms to increase their overall spending, their 
comparative impact on individuals has been somewhat suppressed in the cases of Spain and 
Portugal, but greatly enhanced in the case of Luxembourg.  These results confirm the upward 
convergence scenario in the case of Belgium, Luxembourg, Portugal and Spain, with cross-
over in the cases of Belgium and Portugal (% of GDP) and Belgium and Luxembourg (per 
capita spending). 
 
In looking for countries that reflect the downward convergence scenario, for both health care 
as a percentage of GDP and per capita spending, no countries strictly achieved this, although 
the Netherlands achieves this between 1970 and 1990, and Germany between 1980 and 1990 
for per capita spending, as shown in Figure 6. In contrast to Portugal and Spain, for per 
capita spending the amounts achieved by these two countries are above the corresponding 
values for percentage of GDP spent on health care.  Thus for Germany, percentage of GDP 
lies in the range 115.1% to 134.6% of the EU average, whilst its per capita spending lies in 
the range 143.8 to 166.5% between 1960 and 1995, indicating evidence of a strong 
purchasing power in relation to population size.  A similar but less striking relationship is also 




131.6 for per capita spending between 1960 and 1995. These results show that both countries 
spend well above the EU mean and also have currencies with strong PPP$ values. 
 
Countries which meet the reversal of roles scenario will cross the line of the EU mean, either 
in a downward or upward direction, over the periods examined.  Taking reversal of roles in 
the former case it can be seen that for health care spending as a percentage of GDP (Figure 5) 
this was achieved for Denmark (between 1970 and 1995), Finland (between 1970 and 1980, 
and 1990 and 1995), Ireland (between 1980 and 1995), Sweden (between 1970 and 1995 and 
the UK (between 1960 and 1980).  For per capita spending (Figure 6) this was achieved by 
Denmark (between 1970 and 1995), Finland (between 1970 and 1980, and 1990 and 1995), 
Sweden (between 1970 and 1995) and the UK (between 1960 and 1980).  These findings 
show that Scandinavian countries in particular, which are traditionally associated with strong 
Socialist attitudes to taxation and welfare spending (Esping-Andersen, 1990), have been 
successful in introducing effective policies that have reduced their total expenditure on health 
care in relation to the EU mean.  Moreover, when the UK is included, all these countries 
operate NHS typologies which have been shown to be more effective in controlling 
expenditure due to their centralised and supply-side control mechanisms (OECD, 1994b; 
OECD, 1992; Nixon, 1999). 
 
When examining per capita spending for these countries some interesting observations are 
noted.  For Denmark, spending as a percentage of GDP falls from 123.1% (1970) to 82.8% of 
the EU mean in 1995, while its per capita spending falls from approximately 138.1% to 
92.8% of the EU mean in 1995 (close to parity).  For Finland between 1970 and 1995 
spending as a percentage of GDP falls from 115.1% to 99.7% of the EU mean which 
corresponds to a fall in per capita spending from approximately 106% to 93.1% over the 
same period, indicating that purchasing power for the Finnish currency was below % of GDP 
values. The most visible variations, however, in the relationship between these two variables 
are observed for Ireland in which, for the years 1980 to 1995, its health spending as a 
percentage of GDP achieved a downward reversal of roles, falling from 127.5% to 82.8% of 
the EU mean, while its per capita spending changed from 83.1% in 1980 to a value of 75% of 
the EU mean in 1995, providing evidence of a developing economy and a strengthening of its 
currency. In the case of Sweden we observe that in 1970 Sweden both spent the most in terms 
of percentage of GDP and per capita spending, with values of 143.3% and 175.9 respectively.  
However, over the period 1970 to 1995 it can be seen from Figures 5 and 6 that both variables 
fell to values below the mean of 93.2% and 92.3%, respectively.  Sweden, therefore, has been 
successful in implementing policies to curtail spending on health care which have brought it 
down from its premier position in 1970 to below the EU mean in 1995, and there is evidence 
of a weakening of its economy between the two periods.  
 
Turning now to reversal of roles in an upward direction we can see from Figure 5 that this 
was achieved for only Portugal in terms of % of GDP, with its value rising from a mere 
44.5% of the EU mean in 1960 to 106.1% of the EU mean in 1995.  However, again we 
observe the relative weakness of the Portuguese economy as, for per capita spending, this 
translated itself into figures of 22% in 1960 to 70.2% in 1995.  Spain followed an almost 
identical trend but fell just short of achieving reversal of roles for % of GDP with its figure 
rising from 44.5% of the mean in 1960 to 98.4% in 1995.  These figures for per capita 
spending were translated into values of 25.6% to 72.9% in 1960 and 1995 respectively.  It can 
also be seen from Figure 4 that Italy experienced reversal of roles, or cross-over, between 
1960 and 1990, reaching figures close to parity for per capita spending and % of GDP. Convergence of Health Care Spending and Health Outcomes in the European Union, 1960-95  14
 
In terms of the divergence hypothesis it can be seen that this has been occurring in some 
countries of the EU but not in a consistent manner as there is evidence of movement in both 
directions with respect to the EU mean for a number of countries.  France and Germany 
provide two examples of this in that between 1980 and 1995 there was upwards divergence 
away from the mean in % of GDP spending for France, whilst this occurred for Germany 
between 1990 and 1995.  This indicates that both countries have been committing increasing 
amounts of their GDP for health care.  
 
Belgium and Luxembourg have also achieved divergence in per capita PPP spending for the 
time period 1980-95 (also cross-over as discussed earlier), and especially in the case of 
Luxembourg.  Figure 6 indicates the relative strength per capita spending for Luxembourg 
which was at a value, in 1995, of 149.6% even though its spending as a percentage of GDP 
was only at 90.6% of the EU mean. Greece experienced downward divergence for the period 
1960-80 but achieved upward converge towards the EU mean in both percentage of GDP and 
per capita PPP spending for the period 1980-95.  As in the case of Portugal and Spain, the 
relative position of Greece has been at the bottom of the EU for these two variables since 
1980.  Moreover, the poor purchasing power for Greece is reflected in the fact that although it 
was spending figures around the 60% (range = 52.2 to 75.1%) mark for percentage of GDP 
between 1960 and 1995, it only achieved figures of approximately 40% (range = 29.3 to 47.7) 
in terms of per capita spending.  Thus, whereas other countries have demonstrated large 
swings in their spending on health care the Greek situation has remained relatively stable and 
well below the mean for both spending as a percentage of GDP and per capita spending.   
 
Finally in this section the UK experienced divergence below the EU mean in both percentage 
of GDP and per capita spending between 1970 and 1980, but has begun to converge towards 
the EU mean since then, albeit at a slower rate.  It is interesting to note in Figures 3 and 4 that 
for the UK the relative magnitudes and directions of movement are almost identical, showing 
a strong degree of parity between both variables. 
 
In summary, there are countries which have reduced their expenditures, those which have 
increased their expenditures and those which have remained close to the EU mean.  Countries 
which have achieved increased spending in both percentage of GDP and per capita PPP 
include Belgium, Spain, France, Luxembourg and Portugal.  Countries which have achieved 
reductions relative to the mean for both variables include Austria, Denmark, Finland, Sweden 
and the UK.   
 
Both Italy and Ireland achieved a reduction in percentage of GDP spending but an increase in 
per capita PPP$.  
 
The countries, from these data, which achieved the smallest changes and therefore greatest 
stability would appear to be France and the Netherlands.   
 
4.6  Graphical analysis - health outcomes 
The results of the statistical analyses for health outcomes are shown graphically in the 
following section and based on the σ-convergence between 1960 and 1995. The trends for 
infant mortality, life expectancy (females) and life expectancy (males), again based on an EU 
mean of 100, are shown for the period 1960-95 in Figures 7, 8 and 9, respectively. 
 



































In terms of countries meeting the equivalent growth hypothesis, for infant mortality no 
countries achieved this although Germany comes closest, particularly between 1960 and 
1980, from which point on the figures fall but remain parallel to the mean for 1990 and 1995.  
It is likely that re-unification of the German states in 1989 had an impact on this step 
improvement in infant mortality.  
 
Again, for life expectancy Germany comes closest to equivalent growth for females as shown 
in Figure 8.  In terms of life expectancy for males, the countries closest to fulfilling this 
hypothesis are Belgium, Germany and the UK, all remaining just below or just above (UK) 
the standardised mean of 100 as shown in Figure 9.  
 
















































Countries which meet the upward convergence scenario would indicate a worsening in their 
infant mortality rates with respect to the EU mean.  This occurred for Denmark, the 
Netherlands, Finland (between 1970 and 1990) and Sweden (also between 1970 and 1990).  
In examining life expectancy for females (Figure 8), it can be seen that upward convergence 
was achieved by Austria between 1970 and 1995, Belgium between 1970 and 1995, Portugal 
between 1960 and 1980, and the UK between 1980 and 1995.  For male life expectancy it can Convergence of Health Care Spending and Health Outcomes in the European Union, 1960-95  16
be seen that upward convergence occurred in Austria between 1960 and 1995, Finland 
between 1960 and 1980, and again between 1990 and 1995, and in Portugal between 1960 
and 1990.  
 
When considering the scenario of downward convergence, from Figure 7 it can be seen that 
this was achieved in terms of infant mortality for Italy (between 1960 and 1990) and Portugal.  
The most dramatic improvement was achieved by Portugal which, in 1970, had a standardised 
infant mortality rate almost two and a half times greater than the mean.  Although in 1995 it 
was still above the standardised EU mean, it had figures comparable to Greece and Belgium.  
In examining life expectancy for females (Figure 8) it can be seen that downward 
convergence occurred in the Netherlands between 1960 and 1995, and in Sweden between 
1970 and 1990.  For males (Figure 9), downward convergence occurred in the Netherlands 
between 1960 and 1995, and in Sweden between 1970 and 1990. 
 













































In terms of the achievement of the reversal of roles scenario, countries achieving this would 
change positions over the period examined with respect to the standardised EU mean, in 
either an upward or downward trend.   When infant mortality is considered, Figure 7 reveals 
that the UK experienced upward (worsening) convergence in infant mortality between 1960 
and 1980 and then reversal of roles between 1980 and 1995.  This also occurred for Ireland 
between 1970 and 1995, and Belgium between 1970 and 1995.  Countries experiencing a 
downward (improving) reversal of roles were Austria between 1980 and 1995 and Spain 
between 1960 and 1995.  For life expectancy in females it can be seen that Denmark 
experienced a reversal of roles in a downward (worsening) direction between 1960 and 1995, 
and the UK between 1960 and 1980. In terms of improving reversal of roles, this occurred in 
Spain between 1960 and 1980, in Finland between 1960 and 1980 and again between 1990 
and 1995, in Greece between 1960 and 1995, and in Italy between 1960 and 1990.  For male 
life expectancy, downward (worsening) reversal of roles occurred in Denmark between 1960 
and 1995, in Ireland between 1960 and 1980, and in the UK between 1960 and 1980.  In 
terms of upward (improving) reversal of roles this occurred in France between 1960 and 
1995, Italy between 1960 and 1995, and the UK between 1980 and 1995. 
In terms of infant mortality it can be observed that upward (worsening) divergence occurred 
in the case of Greece between 1960 and 1980 and again between 1990 and 1995, Belgium 




1990 and 1995.  In terms of downward (improving) divergence this occurred for Spain 
between 1990 and 1995 and in Luxembourg between 1990 and 1995. 
 
For female life expectancy the data show that upward divergence (improving) occurred in the 
cases of France and Italy between 1980 and 1995.  Downward convergence (worsening) 
occurred for Germany and Denmark between 1990 and 1995, and Portugal between 1980 and 
1995.  For male life expectancy the results show that upward divergence (improving) 
occurred in the cases of Spain between 1970 and 1980, Italy between 1980 and 1995, and the 
UK between 1990 and 1995.  Downward convergence (worsening) only occurred for 
Denmark between 1990 and 1995. 
 
In summarising the results for health outcomes in terms of their changes with respect to the 
standardised mean over the period 1960-95, the countries with worsening trends in infant 
mortality levels include Belgium, Denmark, France, Finland, Greece, Ireland, The 
Netherlands, Sweden and the UK.  Improving trends with respect to the mean were achieved 
by Austria, Germany, Spain, Italy, Luxembourg and Portugal.  
 
In terms of life expectancy countries with improving (positive) levels include Austria, 
Germany (males only), Spain (females only) France, Finland, Greece, Italy, Luxembourg and 
Portugal.  Countries which achieved worsening (negative) levels include Belgium, Germany 
(females only), Denmark Spain (males only), Ireland, the Netherlands, Sweden and the UK. 
 
Collectively, these trends have led to, and explain, the observed convergence in the two 
statistical tests applied to the health outcome data. It must be stressed here, however, that 
‘worsening’ and ‘improving’ do not reflect actual changes but represent trends with respect to 
the standardised EU mean. 
 
5.  FACTORS INFLUENCING CONVERGENCE  
Although it is beyond the scope of this paper to address all the possible reasons that might 
explain the observed convergence, a brief summary of some key issues, of which some relate 
to membership of the EU, will assist in explaining the findings. Three principal areas are 
discussed, namely theoretical issues which come from the neo-classical growth model and its 
prediction of convergence (Barro and Sala-i-Martin, 1995) in GDP income (and therefore 
convergence in health expenditure), the possible association between the observed health 
expenditure and health outcomes, and in relation to health care systems for those contributing 
most to the results, the health care reforms that were introduced over the period examined, 
principally relating to the 1970s, 80s and 90s. 
 
5.1  Neo-classical growth and observed health expenditure convergence 
The principal points to take from the theoretical base of this paper are that economies with 
similar tastes and technologies tend to converge to the same steady state, economies which 
start out proportionally below their steady states tend to grow faster than rich ones, and 
regional convergence within countries is more easily achieved than across countries due to 
the presence of homogeneity of culture, religion, language, law and politics.  The latter points 
in particular have a controlling effect on the mobility of capital and labour and the principle to 
grasp here is that the allowance of migration in neo-classical growth models tends to 
accelerate the process of convergence.  Before its conception, former EU countries were far 
more closed and homogenous, and lacked the means to achieve greater convergence as 
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barriers to convergence to be broken down.  Many aspects of EU social and agricultural 
policy encourage the re-distribution of wealth by offering subsidies and financial assistance to 
poorer regions of the EU.  The principles of worker mobility and free trade as laid out in the 
‘four freedoms’ of the 1985 Single European Act and the 1991 Maastricht Treaty increasingly 
mean that citizens of the EU have, through increased knowledge, education and mobility, 
come and continue to expect similar rights and provision in terms of economic opportunity.  
The underlying principles of the neo-classical growth model therefore have applicability to 
the study of convergence in health care expenditure as there is a strong correlation between 
the latter and GDP income (Hitiris, 1997; OECD, 1995).  The data on GDP income were also 
analysed for convergence for the period 1980-95 and this confirmed that faith in the neo-
classical growth model for EU countries is justified.  The findings provided statistically 




5.2  Associations between health expenditure and health outcomes 
The question one might wish to pose based on the finding of convergence in both health care 
expenditure and health outcomes is, ‘does a causal relationship exist between them?’ 
 
As Goldacre (1996, p.69) points out, however, ‘the difficulty of isolating the contribution of 
the health service ‘input’ as a determinant of health status ‘output’ is one which frustrates 
attempts to measure the overall effectiveness and efficiency of health care.’ As he argues, in 
comparing trends within a country over time there is no experimental control group providing 
comparable data in the absence of health services. Only a few studies have been successful in 
finding a causal link between health expenditure and health outcomes as other factors such as 
diet, lifestyle and environment are often taken to be the principal factors affecting health 
outcomes, particularly when considering life expectancy (Folland et al, 1993).  Another 
restricting factor that has been cited is the heterogeneity in data used in cross-national studies 
(Cremiéux et al., 1999).  Moreover, a full investigation of this potential link for the above 
analyses is not feasible within the constraints of the present study. 
 
In the following, therefore, only a brief summary of trends in health expenditure in 
comparison with health outcomes, and correlation values for each, are provided. 
 
The results have shown that six countries achieved increases in per capita health expenditure 
with respect to their standardised values between 1960 and 1995.  These countries are 
(relative changes for standardised values in brackets) Belgium (+16.0), France (+0.2), Spain 
(+47.3), Greece (+18.4), Italy (+10.8), Ireland (+7.3), Luxembourg (+58.2) and Portugal 
(+48.3).  It is worth noting that all the countries of the Southern Mediterranean are included in 
this category. Among these, increased expenditure has resulted in improvements in all three 
health outcome measures for Italy, Luxembourg and Portugal, improvements in both life 
expectancy indicators for Greece, and improvements in life expectancy for females as well as 
infant mortality in Spain.  It is also interesting to note that increased expenditure for Belgium 
and Ireland was associated with a worsening trend of all three health outcome indicators in 
relation to the standardised EU mean. 
 
In contrast the results show that 8 countries experienced a reduction in their standardised per 
capita health expenditure levels between 1960 and 1995.  These countries are Austria (-11.7), 
                                                 




Germany (-21.7), Denmark (-29.8), Finland (-7.5), the Netherlands (-7.2), Sweden (-72.4) and 
the UK (-56.3).  It is notable that all the countries of Scandinavia (including Finland) are in 
this group.  Decreased standardised per capita expenditure resulted in a worsening (with 
respect to the EU mean) of all three health outcome measures in Denmark, the Netherlands, 
the UK and Sweden.  Both France and Finland had worsening infant mortality rates and 
Germany had a slight worsening in its life expectancy for males. 
 
A correlation coefficient was determined for each health outcome with respect to per capita 
health expenditure.  Between per capita health expenditure and infant mortality a high 
correlation was observed at a value of -0.58. This tells us that as per capita health expenditure 
increases, infant mortality decreases, and vice-versa.  
 
For life expectancy the results are less convincing, with a value of +0.289 for female life 
expectancy, showing that as per capita health expenditure increases so does female life 
expectancy, but to a lesser degree compared with infant mortality.  For male life expectancy, 
the correlation coefficient was only -0.05, indicating virtually no correlation.   
 
The signs of these correlations are generally supportive of an association between health 
expenditure and health outcomes but statistical tests of significance for a causal link will 
require more detailed analyses.  
 
 5.3  Health Care Reforms 
Reforms of health care financing have been examined in a number of studies attempting to 
analyse their effect (Ham et al., 1990; OECD, 1992; OECD, 1994b).  The principal aim of the 
reforms has been to achieve efficiency at both the macro-economic and micro-economic 
levels. Ham (1997) and other authors from selected countries of the EU provide a valuable 
and up to date summary of reforms over the period of interest. The general theme raised by 
these reforms is that most countries are under continuing pressure to ‘contain costs, increase 
efficiency and raise service standards’ (ibid, p.1).  Four countries included in the analysis are 
full members of the EU and as Ham suggests, reforms introduced in these countries provide 
general principles that can be applied in various ways to countries embarked on the agenda 
identified above, and that they contain a range of typologies in the delivery of health care 
(NHS, social insurance and private insurance as well as public and private providers). 
 
The specific strategies adopted by various member states of the EU have included the ‘big 
bang’ (Klein, 1995) market-type reforms of the UK in the 80s and 90s with the introduction 
of an ‘internal market’ approach which divided the NHS into ‘purchasers’ and ‘providers’.  In 
countries such as the Netherlands and Germany, however, the focus has been on an 
‘incremental’ approach which has placed competition at the division between ‘insurance 
companies’ and ‘providers,’ reflecting the nature of these systems as social insurance models.  
Moreover, due to the differences in political systems between countries such as the UK and 
the Netherlands, namely majority government versus consensus government, the incremental 
approach has taken much longer to implement as exemplified by the Plan-Dekker, Plan-
Simons reforms which created the foundation for reforms in the Netherlands but remain 
incomplete in terms of implementation (Van de Ven, 1997).  The third type of reform has 
come about as a result of a ‘bottom-up’ approach as witnessed in the case of Sweden 
(Rehnberg, 1997), which is characterised by its use of county councils to implement health 
care at a local level. 
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In contributing to the downward and reversal of roles scenarios of convergence the countries 
of Scandinavia are highly relevant. In the case of Sweden, the most striking of all 
Scandinavian countries in terms of achieving cost containment since the 1970s, Rehnberg 
(1997) explains that the budget system used to allocate resources in the 1960s and 1970s 
suffered from overspending by clinical departments which the county councils in Sweden 
largely ignored.  However, this situation was redressed by reforms in the 1980s that 
introduced global budgets which were capped.  To further control health care spending, 
central government regulated total expenditure by placing limits on the amount of revenue 
that could be raised by county councils.  Thus, unlike some other OECD countries, 
particularly those with private and social insurance systems, Sweden has been highly 
successful in containing its health care expenditure and is now not only close to the EU mean 
but is also close to the OECD mean (ibid).  The analysis here confirms that Scandinavian 
countries in general, but Sweden and Denmark in particular, have introduced effective 
reforms to reduce their health care expenditures. 
 
Moreover, analysis of health care expenditure shows that countries with NHS modes of 
delivery, such as Sweden, are associated with a lower mean value  than those of social 
insurance models operated by other countries in the EU (Nixon, 1999). As such, they are 
more effective in controlling public expenditure on health care.  This is reflected in Figures 5 
and 6 for 1995 as the majority of EU countries with NHS typologies are below the EU mean 
for percentage of GDP (Denmark, Finland, Greece, Italy, Spain, Sweden and the UK) and per 
capita PPP$ (Denmark, Finland, Greece, Portugal, Spain, Sweden and the UK).  In contrast 
all social insurance countries except Luxembourg are above the EU mean (Austria, Belgium, 
France, Germany and the Netherlands) for % of GDP and all are above the EU mean for per 
capita spending.  
 
Studies by the OECD (1992; 1994b) add support to this analysis in providing evidence to 
show that integrated models appear to be the most successful in containing costs followed by 
contract models and reimbursement models.  This is attributable to the economies of scale 
that more centralised, integrated models can achieve as well as centralised control of national 
expenditure. 
 
In contrast, while some countries have been striving to contain public expenditure on health 
care, the Southern Mediterranean countries of Spain, Portugal and Greece (also Luxembourg), 
as demonstrated in the analysis, have been increasing their commitment towards health 
expenditure and have achieved upward convergence towards the EU mean, as well as reversal 
of roles above the mean,  for at least one of the variables analysed.  Essentially this is due to 
the fact that these countries started at a comparatively low point with respect to other EU (and 
OECD) countries in 1960 for various reasons.  In the case of Greece, Spain and Portugal this 
was due to factors such as political turmoil, the after-effects of revolution or social 
inequalities and inward migration (in the case of Portugal), and poor GDP performance.  In 
the section below the cases of Spain and Portugal are outlined. 
 
Health care provision in the post-war period in Portugal was characterised by variable 
provision.  The responsibility for paying for health care either lay in the hands of individuals 
or their families, the government for selected groups such as civil servants, or was met by the 
misericordias which were religious charity hospitals.  The government’s role was a secondary 
one in that it filled in the gaps left by private initiatives and gave priority to preventive 




geographical location, with the better quality services being located in Lisbon, Oporto and 
Coimbra.  The need to expand its services can be illustrated by the low numbers of health 
professionals, which in 1970 included one doctor per 1,115 of population, of which there was 
one specialist per 2,636 of population, and only one fully qualified nurse per 1,600 of 
population (ibid).  Essentially the standard of service was low, services were fragmented and 
dissatisfaction was felt by both consumers and professional with services provided by the 
government.  However, in 1965 and 1968 laws were passed to provide powers for the 
financing and organisation of primary health care and in 1979 a national health service was 
introduced. 
 
The trends in health care provision can clearly be seen from INE  Health Statistics for 1970, 
1980 and 1990 (OECD, 1994b, p. 252) which shed some light on the consequences of 
increased expenditure and the move, more latterly, towards private health provision in 
Portugal.  If we examine the mix of health institutions, in 1970 there were 171 government 
hospitals, 284 misericordias, and 160 private hospitals.  In 1980 these figures had altered to 
394 government hospitals, 8 misericordias and 89 private hospitals and by 1990 the figures 
had altered dramatically such that there were only 145 government hospitals, no 
misericordias and a total of 95 private hospitals.  Similarly, the number of doctors increased 
from 8,580 in 1970 to 28,852 in 1990 whilst the number of nurses increased from 10,000 to 
27,652 over the same period.  These statistics are indicative of a complete switch away from 
relying on charity hospitals to more pluralistic modes of meeting health care needs and 
increased health expenditures within the overall context of an NHS mode of delivery.  
 
In the case of Spain before the reforms in the 1980s its health care system was also 
characterised by variability and dominated by a compulsory health insurance system, Instituto 
Nacional de la Salud (INSALUD), which was part of the social security system.  INSALUD 
covered approximately 90% of the population and as such gaps existed in terms of provision, 
with the poor and unemployed in society being excluded from INSALUD-financed care.   
Other major weaknesses in health care in Spain at that time included complaints concerning 
the inadequate levels of public spending, a view that the public sector was inefficient and 
impersonal,  long waiting lists and overcrowded emergency departments, and stresses and 
strains at the complex and permeable boundaries between public and private sectors caused 
by doctors dividing their attentions between them to the disadvantage of the public patients 
(OECD, 1994b; Miguel and Guillen, 1989; Rodriguez, et al.,1990).  Brooks (1987) 
summarises the situation in the pre-reformed public sector as being fragmented, poorly co-
ordinated, over-bureaucratic and under-managed. 
 
The response of the Spanish government during reforms introduced in the 1980s included the 
consolidation of a National Health System, the extension of compulsory health to virtually the 
entire population, better planning and integration of both primary and hospital care, increased 
reliance on funding from general taxation and the beginning of the devolution of health care 
administration to the autonomous regions (OECD, 1992, p. 103).  As a result both percentage 
of GDP and per capita spending rose as indicated by the results of this paper.  Specifically 
referring to the concept of achieving greater convergence the 1992 Reform stated ‘Within the 
framework of a government strategy of European convergence, (there was a) decision to 
move towards a greater autonomy of hospitals, (to be) converted into quasi-public 
corporations’ (OECD, 1992, p.109).  
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Thus it may be reasonable to conclude that for countries such as Portugal and Spain, a number 
of factors relating to their economies and populations have meant that they have had a good 
deal of catching up to do but have been making inroads and are converging on and even 
exceeding (Portugal for % of GDP) the EU mean, at least over the period of analysis 
addressed in this paper.  Greece, on the other hand, which shares a number of socio-economic 
features with Spain and Portugal, has achieve the same trend to a somewhat lesser degree. 
However, as many studies have shown (c.f. Hitiris, 1997; OECD, 1995), there is a strong 
correlation between health care expenditure and GDP wealth and Greece, in terms of this 
latter point, has not managed to achieve growths in GDP commensurate with its EU partners.  
As such, it might be concluded from the perspective of Greece, that whilst strong divisions 
remain in terms of GDP wealth in the countries of the EU, convergence will be limited. 
 
6.  CONCLUSIONS 
The results have demonstrated that statistically significant convergence in health care 
expenditure and health outcomes occurred in the present countries of the EU over the period 
1960-95 for σ-convergence and 1980-95 for β-convergence. 
 
The first method tested for a reduction in standard deviation of the standardised values, 
around a mean of 100, which is equivalent to examining the coefficient of variation and 
overcomes the problems of changes in magnitude in variables over time.  This method, 
however, has some limitations in that it looks at the data cross-sectionally at discrete time 
intervals and cannot determine if countries approaching the mean will reduce their rates of 
growth in order to follow a parallel path with the mean. This limitation is overcome by 
regression to the mean analysis, indicated by a negative value for β in the regression models 
used.  The use of panel data also minimises the influence of inconsistent trends between 
points of analysis and outliers. As such both approaches are informative and complement 
each other in understanding the concepts of convergence analyses. The analyses presented 
here have also revealed which countries have produced such trends. 
 
The results for health expenditure have shown that the countries of the Southern 
Mediterranean have been prominent in improving their expenditure levels over the periods of 
analysis and these have generally been associated with improvements in health outcomes, 
particularly in infant mortality rates.  At the same time, the relative strengths of these 
countries’ economies have revealed that although at a policy level (share of GDP) they are 
converging upwards towards the EU mean there is less of an impact at the per capita levels, 
although convergence is also maintained for this variable. 
 
In contrast, countries of the North, Particularly Sweden and Denmark, have achieved greater 
control over their health expenditures and have converged markedly to a position on or below 
the EU mean over the period of analysis.  Other countries, such as the UK, have also 
exhibited downward trends in their health expenditure levels but these have not been as great 
as those of the Scandinavian countries which have come down from much higher levels.  In a 
similar manner health outcomes for those countries reducing their health expenditures have 
experienced worsening health outcomes in relation to the EU mean, although in absolute 
terms trends for these countries have continued to improve but with a diminution in advantage 
over the EU mean value. 
 
When examining correlations between health expenditure and health outcomes the expected 




that infant mortality reduces with increasing health care expenditure and life expectancy for 
females increases.  The correlation for male life expectancy, however, suggests little impact.  
It must be noted, however, that this association will need further regression analyses to 
establish a causal link and most studies in the past have failed to establish such a relationship. 
 
In terms of explaining the results three factors were explored.  The well-established link 
between income and health care expenditure in the context of convergence throughout the EU 
in GDP income confirms the predictions of the neo-classical growth model.  This is the 
theoretical base of the study and is anticipated to be highly relevant to the countries of the EU 
which have a high degree of homogeneity in relation to technology and social structures, 
which, coupled with the freedom of movement of the factors of production and mechanisms 
for the re-distribution of wealth, tend to be drivers for greater convergence through a process 
of increasing integration. 
 
For three countries which have contributed greatly to the observed convergence in health 
expenditure the reforms of the 1970s 80s and 90s were examined.  Sweden has achieved 
effective reforms that have benefited from moves towards central planning and budgeting.  In 
contrast, Spain and Portugal (to a lesser extent Greece), have increased their expenditure 
levels as a share of GDP towards the EU mean although these increases have not been met 
with such dramatic increases in per capita spending. Over the same period Luxembourg has 
achieved per capita spending levels well above its associated percentage of GDP spending.  
This point reveals an important finding of the analysis in that the relative strengths of 
currencies’ purchasing power and the size of GDP in relation to population affect per capita 
spending figures. 
 
In terms of reforms, even though the specific response has varied from country to country the 
same fundamental objectives have been evident, namely the need to contain costs, increase 
efficiency and raise service standards.  Some countries with the characteristics of strong 
government in terms of decision-making, such as Sweden and the UK, have been able to 
introduce radical market reforms in a relatively short space of time which has led to the label 
of ‘big bang’ being attached to them. Sweden, with its bottom-up approach, has achieved 
effective control of its health care expenditure and has gone from being at the top of the tree 
in 1960 to a position just below the EU mean in 1995.  Other countries with consensus 
governments, such as the Netherlands, have adopted an incremental approach which has 
resulted in a slower process in terms of implementation. In contrast, a number of countries 
have had a good deal of catching up to do and have increased their expenditures accordingly, 
noticeably the countries of the Southern Mediterranean. 
 
The findings also suggest that greater convergence will occur in the future when greater 
equality in relation to the purchasing powers of EU currencies is achieved, which may well be 
a consequence of the process of Economic Monetary Union (EMU).  The question of 
inequalities in GDP wealth remains a barrier to greater convergence due to the strong 
correlation between GDP and health care expenditure.  For policy makers, the question of 
system typology should also not be ignored as previous analysis has shown an association 
between health care spending and NHS or social insurance models of delivery (Nixon, 1999).  
Over the period studied, the number of countries adopting NHS modes of delivery has 
increased (Italy, Spain, Portugal and Greece). 
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From a societal perspective the measurement of convergence in social welfare provision such 
as health care is by no means a futile exercise as its presence tells us that things are becoming 
more similar over time, which implies a greater degree of equality and integration is being 
achieved within the countries of the EU.  However it remains to be seen if this is due to or in 
spite of EU social policy on health care as many countries have not been members of the EU 
throughout the period examined, no overt policy exists in terms of EU health care, and 
subsidiarity remains the guiding principle.  However, the analyses conducted here show the 
relative positions of countries with respect to the EU mean and provides an indication of how 
greater cohesion can be achieved, perhaps aided by current and future measures that re-
distribute wealth or resources within the EU.  Further research will attempt more closely to 
identify economic and policy measures which have had an influence on the convergence 
demonstrated in this analysis.  The methodology adopted here would be suitable for a wide 
range of applications in relation to analyses examining social and economic trends towards 
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